HB-401

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHB-401

Drug Alias Namerecombinant LCMV vector neo-antigen vaccine (Hookipa Therapeutics)HB-401

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHookipa Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A